Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines - Takeaways - MDSpire

Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines

  • By

  • Li-Yun Lin

  • Pierre Gantner

  • Shuang Li

  • Bin Su

  • Christiane Moog

  • September 20, 2024

  • 0 min

Share

  • 1

    Vaccines for HIV and SARS-CoV-2 must induce neutralizing antibodies (NAbs) for effective protection against these viruses.

  • 2

    Fc-mediated inhibitory antibodies may enhance immune defense by countering virus mutations and broadening the protective antibody response.

  • 3

    HIV's high mutation rate and glycosylation mask functional epitopes, complicating the induction of effective neutralizing antibodies.

  • 4

    SARS-CoV-2 vaccines induce NAbs but protection decreases with new variants, indicating a potential role for non-neutralizing antibodies.

  • 5

    Understanding the mechanisms of antibody-mediated protection is crucial for developing next-generation vaccines against HIV and SARS-CoV-2.

Original Source(s)

Unpredicted Protective Function of Fc-Mediated Inhibitory Antibodies for HIV and SARS-CoV-2 Vaccines

  • by Li-Yun Lin, Pierre Gantner, Shuang Li, Bin Su, Christiane Moog

  • September 20, 2024

Related Content

SARS-CoV-2 and reproductive system: a scientometric study

Serum cytokine profiling reveals CXCL10 (IP-10) as a major predictor of severe COVID-19 outcomes in hospitalized patients during the first pandemic wave in Italy

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.